BEMA Fentanyl Demonstrates Substantial Transmucosal Delivery


BioDelivery Sciences International, Inc. (Nasdaq:BDSI) have announced the results of a 12 subject, crossover study comparing the absorption of fentanyl from both single and multiple BEMA” Fentanyl discs, as well as oral and intravenous doses of fentanyl. The data demonstrates that the absolute bioavailability (i.e. [click link for full article]



Leave a Reply

You must be logged in to post a comment.